Loading...
Loading...
Browse all stories on DeepNewz
VisitGlobal Fund and PEPFAR to Distribute Lenacapavir, 100% Success Rate, to 2 Million People by 2026
Dec 17, 2024, 03:09 PM
A new long-acting preventive drug for HIV, known as Lenacapavir, is set to be distributed in the world's poorest countries by late 2025 or early 2026. This initiative is part of a coordinated effort by the Global Fund and PEPFAR, aiming to reach 2 million people with the drug, which has shown 100% success in trials. Health officials believe that this drug could significantly reduce global HIV infections and accelerate the fight against the virus by 2030.
View original story
Markets
Yes • 50%
No • 50%
Official announcements from Global Fund and PEPFAR, news reports
Yes • 50%
No • 50%
Reports from Global Fund and PEPFAR, official press releases, and health organization updates
Yes • 50%
No • 50%
Clinical studies, health organization reports, and peer-reviewed publications
WHO • 25%
Global Fund • 25%
PEPFAR • 25%
UNAIDS • 25%
Reports from Global Fund, PEPFAR, UNAIDS, and WHO
Logistical challenges • 25%
Regulatory hurdles • 25%
Funding issues • 25%
Other • 25%
Reports from Global Fund, PEPFAR, and health organizations, news articles
Sub-Saharan Africa • 25%
South Asia • 25%
Southeast Asia • 25%
Latin America • 25%
Distribution reports from Global Fund and PEPFAR, regional health organization updates